- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- December 2024
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- March 2025
- 196 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 193 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
- 143 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- October 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- July 2024
- 158 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- August 2024
- 96 Pages
North America
From €5456EUR$5,995USD£4,677GBP
- Report
- August 2024
- 135 Pages
Europe
From €5456EUR$5,995USD£4,677GBP
- Report
- August 2024
- 126 Pages
Asia Pacific
From €5456EUR$5,995USD£4,677GBP
- Report
- July 2022
- 100 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- May 2022
- 70 Pages
North America
From €1365EUR$1,500USD£1,170GBP
- Report
- July 2024
- 43 Pages
Canada
From €4546EUR$4,995USD£3,897GBP
- Report
- July 2024
- 42 Pages
Australia
From €4546EUR$4,995USD£3,897GBP
- Report
- July 2024
- 36 Pages
India
From €4546EUR$4,995USD£3,897GBP
- Report
- July 2024
- 39 Pages
Germany
From €4546EUR$4,995USD£3,897GBP
- Report
- July 2024
- 45 Pages
France
From €4546EUR$4,995USD£3,897GBP
- Report
- May 2022
- 221 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- January 2022
Global
From €6826EUR$7,500USD£5,852GBP

Within the realm of cardiovascular devices, mechanical circulatory support (MCS) devices are engineered to assist or replace the pumping function of the heart in patients with severe heart failure or during cardiac procedures. This subset of devices encompasses a range of products including ventricular assist devices (VADs), total artificial hearts (TAHs), and intra-aortic balloon pumps (IABPs). The market for MCS devices is driven by technological advancements, the prevalence of heart failure, and the need for supportive interventions in cardiac surgeries. VADs can be utilized as a bridge to transplantation, a bridge to recovery, or as a destination therapy, catering to different patient needs. Ongoing research and development aim at improving the durability, biocompatibility, and functionality of these devices, thereby enhancing patient outcomes and quality of life.
Several companies are recognized contributors in the mechanical circulatory support devices market. Notable among them is Medtronic, which offers a range of cardiac and vascular therapies. St. Jude Medical, now part of Abbott Laboratories, provides various MCS solutions after Abbott's acquisition. Thoratec Corporation, acquired by St. Jude Medical, was historically a specialist in VADs. SynCardia Systems, Inc. is known for their total artificial heart as a bridge to transplant. Berlin Heart GmbH offers ventricular assist devices catering to both adult and pediatric patients. Lastly, MAQUET Holding B.V. & Co. KG, part of the GETINGE GROUP, provides intra-aortic balloon Show Less Read more